• Your Trusted Usenet Provider
  • Secure, Private, Unlimited

Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine

Lyme disease ( sci.med.diseases.lyme )
 
From pal@monkeypa.demon.co.uk Tue Mar  7 16:37:05 1995
Path: uunet!bounce-back
From: Linda Palund <pal@monkeypa.demon.co.uk>
Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology
Subject: RFD: misc.health.lyme-disease
Followup-To: news.groups
Date: 7 Mar 1995 15:34:58 -0500
Organization: monkeypa.demon.co.uk
Lines: 112
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <3jig1i$nl9@rodan.UU.NET>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:6345 news.groups:137985 alt.med.fibromyalgia:15690 alt.support.arthritis:3185 misc.health.arthritis:880 sci.med:119451 sci.med.immunology:1090

                        REQUEST FOR DISCUSSION

PROPOSED GROUP:

misc.health.lyme-disease        Lyme Disease and related issues.
                                Unmoderated.


This is a formal Request For Discussion concerning the creation of an
unmoderated newsgroup to be called misc.health.lyme-disease.  This RFD
is being posted in accordance with the Guidelines for Newgroup
Creation.  Its language is based on previously submitted RFDs.  Its
format follows a suggestion by David C. Lawrence, the moderator of
news.announce.newgroups.


RATIONALE:

There is currently no discussion group for the many persons suffering
>from Lyme Disease, a devastating illness which is prevalent all over
the world, between the same latitudes and wherever the disease
carrying tick thrives.  This disease has become a problem from North
America to Slovakia and beyond, with symptoms as varied as the
terrain. Patients are often left isolated by their debilitating
symptoms in quite rural locations.

Because their activities often take them into areas where the tick is
found, Lyme Disease is particularly common among teenagers and young
children.  Fortunately, many of these young people have access to a
computer, usually through their school. Both young patients and adult
sufferers may never actually meet another Lyme Disease patient face
to face, and being able to communicate via a Lyme Disease newsgroup
could be invaluable help in easing their fears and giving them the
support they need, for although there are Lyme Disease support groups
in various geographic locations, the severe limitations of the varied
symptoms experienced by patients make it often impossible for them to
physically attend these groups. This proposed newsgroup would give
housebound patients a much needed forum to discuss their
problems,symptoms, fears and victories.


MAILING LISTS:

There currently exists a Lyme Disease Mailing List, LymeNet, which
publishes an informational newsletter to its 1200 direct subscribers,
as well as being gated to the sci.med newsgroup.  In addition, I am
aware that many people copy the LymeNet Newsletter and redistribute
it as per the reprint agreement.

LymeNet is useful for the dissemination of new information about Lyme
disease as it is made available and will definitely be useful as a
resource for the proposed discussion group, but it is not able to
offer the give and take that an open discussion group can offer and
the publishers of LymeNet have no plans to make such a discussion
group available to all sites.  I am planning to ask the publishers to
gateway the LymeNet Mailing List to misc.health.lyme-disease.


CHARTER:

The proposed newsgroup would be intended for discussion about the many
different aspects of Lyme Disease as experienced by patients, their
caregivers, friends and family members, doctors and other medical
professionals, or anyone affected by or involved with Lyme Disease.

Anyone with an interest in Lyme Disease is free to post, including the
medical and scientific community, but this newsgroup is mainly
interested in fostering communication between Lyme Disease sufferers
>from all parts of the globe, rather than purely medical or scientific
debate, although these discussions will be welcome for informational
purposes.

The following are examples of possible posting topics:

- symptoms and questions arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community confronting Lyme Disease
- new information and resources available about this illness
- related practical problems and solutions

Commercial advertisements may NOT be posted to this proposed group.


PROCEDURE:

After a discussion period of 21-30 days, and if there are no
overwhelming objections to the proposed group, there will be a Call
For Votes (CFV) posted to the same groups as this RFD.  The voting
period will be at least 21 days.  If the group passes by receiving
a 2/3rds majority of YES votes to all valid YES & NO votes as well as
100 more YES votes than NO votes, it will be created.


DISTRIBUTION:

This RFD is being posted to the following relevant newsgroups:

  news.announce.newgroups, news.groups
  alt.med.fibromyalgia, alt.support.arthritis, misc.health.arthritis
  sci.med, sci.med.immunology

Subsequent discussion should take place in news.groups, or by
private e-mail to the proponent.  The headers of this message are
set to direct standard Usenet software to do this automatically.
Please send a copy of every followup article to the proponent as
well to avoid being accidentally ignored.


Proposed by:    Linda Palund     <pal@monkeypa.demon.co.uk>
Mentor:         Taneli Huuskonen <huuskone@cc.helsinki.fi>

From monkeypa@dircon.co.uk Thu May 25 18:47:02 1995
Path: uunet!bounce-back
From: Linda Palund <monkeypa@dircon.co.uk>
Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology
Subject: 2nd RFD: sci.med.diseases.lyme
Date: 23 May 1995 15:33:44 -0400
Organization: Monkeypaw Productions
Lines: 133
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <3ptdao$psk@rodan.UU.NET>
NNTP-Posting-Host: rodan.uu.net
Folloup-To: news.groups
Xref: gs2.UU.NET news.announce.newgroups:6874 news.groups:150933 alt.med.fibromyalgia:23106 alt.support.arthritis:4144 misc.health.arthritis:1641 sci.med:128965 sci.med.immunology:1650

                     REQUEST FOR DISCUSSION (RFD)
               unmoderated group sci.med.diseases.lyme

   changed proposal from unmoderated group misc.health.lyme-disease

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease and related issues.


This is a formal Request For Discussion concerning the creation of an
unmoderated newsgroup to be called sci.med.diseases.lyme.

This is the same group that was recently proposed under the title of
misc.health.lyme-disease.  After a long discussion period it was
decided by consensus that the misc.health category was not the best
choice for a Lyme Disease discussion group for the following reasons:
Many of the respondents were unable to access the misc category at
their sites.  In addition, the consensus felt that the sci.med
category would better serve their desires to have a serious as well as
informative and accessible forum for discussion and would encourage
the participation of the medical and scientific community.  Therefore
we are posting the RFD again under the new name of
sci.med.diseases.lyme.

The first paragraph of the Charter has been amended to include anyone who
has an interest in educating themselves about the symptoms, treatment, and
prevention of Lyme Disease. The second paragraph of the Charter has been
changed to reflect the wishes of the consensus to encourage participation
by the medical and scientific community.  Other changes that have been made
are inessential corrections in wording to clarify the language of the RFD.


This RFD is being posted in accordance with the Guidelines for Newsgroup
Creation.  Its language is based on previously submitted RFDs.  Its
format follows a suggestion by David C. Lawrence, the moderator of
news.announce.newgroups.


RATIONALE:

There is currently no discussion group for the many persons suffering from
Lyme Disease, a devastating illness which has become a problem from North
America to Slovakia or wherever the disease carrying tick thrives. The
symptoms are as varied as the terrain and patients are often left isolated
by these debilitating symptoms in quite rural locations.

Although there are Lyme Disease support groups in various geographic
locations, the severe limitations of the varied symptoms experienced by
patients make it often impossible for them to physically attend these
groups. This proposed newsgroup would give housebound patients a much
needed forum to discuss their problems, symptoms, fears and victories. Lyme
Disease is particularly common among teenagers and young children because
their activities often take them into areas where the tick is found.
Fortunately, many of these young people have access to a computer, usually
through their school. Both young patients and adult sufferers may never
actually meet another Lyme Disease patient face to face, and being able to
communicate via a Lyme Disease newsgroup could be invaluable help in easing
their fears and giving them the support they need.

MAILING LISTS:

There currently exists a Lyme Disease Mailing List, LymeNet, which publishes
an informational newsletter to its 1200 direct subscribers, as well as
being gated to the sci.med newsgroup.  In addition, I am aware that many
people copy the LymeNet Newsletter and redistribute it as per the reprint
agreement.

LymeNet is useful for the dissemination of new information about Lyme
Disease as it is made available and will definitely be useful as a resource
for the proposed discussion group, however it is not able to offer the give
and take that an open discussion group can offer and the publishers of
LymeNet have no plans to make such a discussion group available to all
sites.  We are planning to gateway the LymeNet Mailing List to
sci.med.diseases.lyme.


CHARTER:

The proposed newsgroup is intended for discussion about the many different
aspects of Lyme Disease as experienced by patients, their caregivers,
friends and family members, doctors and other medical professionals, or
anyone affected by or involved with Lyme Disease, as well as those who wish
to learn about its symptoms, latest treatment options and its prevention.

Anyone with an interest in Lyme Disease is free to post, including the
medical and scientific community, as this newsgroup is interested both in
fostering communication between Lyme Disease sufferers from all parts of
the globe, as well as providing an open forum for the exchange of medical
and scientific information which can be useful to all participants.  Above
all, we wish to encourage a supportive and open atmosphere for the free
exchange of opinions and information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness

- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.


PROCEDURE:

If there are no overwhelming objections to the proposed group, there will
be a Call For Votes (CFV) posted to the same groups as this RFD.  The
voting period will be at least 21 days.  If the group passes by receiving a
2/3rds majority of YES votes to all valid YES & NO votes as well as 100
more YES votes than NO votes, it will be created.


DISTRIBUTION:

This RFD is being posted to the following relevant newsgroups:

        news.announce.newgroups, news.groups
        alt.med.fibromyalgia
        alt.support.arthritis, misc.health.arthritis
        sci.med, sci.med.immunology


Subsequent discussion should take place in news.groups only, not in
other above-mentioned groups.  The Followup-To: header is set
accordingly.

Proposed by:    Linda Palund     <monkeypa@dircon.co.uk>
Mentor:         Taneli Huuskonen <huuskone@cc.helsinki.fi>

From warren@syra.net Wed Jun 21 16:42:56 1995
Status: RO
Path: uunet!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: CFV: sci.med.diseases.lyme
Followup-To: poster
Date: 21 Jun 1995 01:20:48 -0400
Organization: Usenet Volunteer Votetakers
Lines: 125
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 13 Jul 1995 00:00:00 GMT
Message-ID: <sci.med.diseases.lyme-CFV1@uunet.uu.net>
References: <3ptdao$psk@rodan.UU.NET>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7077 news.groups:154650 sci.med:132685 sci.med.immunology:1864 alt.med.fibromyalgia:25373 alt.support.arthritis:4562 misc.health.arthritis:1930 bionet.microbiology:2566 sci.bio.microbiology:1137

                          FIRST CALL FOR VOTES (of 2)
                   unmoderated group sci.med.diseases.lyme

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

Votes must be received by 23:59:59 UTC, 12 July 1995.

This vote is being conducted by a neutral third party.  For voting
questions only contact Warren Lavallee <warren@Syra.NET>.  For
questions about the proposed group contact Linda Palund
<monkeypa@dircon.co.uk>.

DISTRIBUTION
This CFV has been cross posted to:

  sci.med, sci.med.immunology, alt.med.fibromyalgia,
  alt.support.arthritis, misc.health.arthritis, bionet.microbiology,
  sci.bio.microbiology

And EMailed to:
	LymeNet <lymenet-l@lehigh.edu>

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

RATIONALE

        There is currently no discussion group for the many persons
suffering from or involved with Lyme Disease. The symptoms of Lyme
Disease are as varied as the terrain in which the disease carrying tick
thrives, and patients are often left isolated by their debilitating
symptoms in quite rural locations. Although there are Lyme Disease
support groups in various geographic locations, the severe limitations
of the symptoms experienced by patients make it often impossible for
them to physically attend these groups. This proposed newsgroup would
give housebound patients a much needed forum to discuss the disease,
as well as giving them the support they need. It will also enable
researchers and doctors from all over the medical and scientific
community who are studying this disease, to communicate via the Lyme
Disease newsgroup and could be invaluable help in the dissemination of
useful information to all persons concerned with Lyme
Disease.


HOW TO VOTE

Send MAIL to:   voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.

Your mail message should contain *one* and only one of the following
statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.
      I vote YES on sci.med.diseases.lyme
      I vote NO on sci.med.diseases.lyme
      I vote ABSTAIN on sci.med.diseases.lyme
      I CANCEL my vote on sci.med.diseases.lyme

Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)

Anything else may be rejected by the automatic vote counting program.  The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.

If you later change your mind you may vote again; only your last valid
vote will count.

Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)

In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.

If you give anyone a copy of the CFV, it must be whole and unmodified.

When in doubt, ask the votetaker.

Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.

The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.

There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.

From warren@syra.net Tue Jul 11 13:28:22 1995
Status: RO
Path: uunet!in1.uu.net!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: 2nd CFV: sci.med.diseases.lyme
Followup-To: news.groups
Date: 10 Jul 1995 18:18:46 -0400
Organization: Usenet Volunteer Votetakers
Lines: 125
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 13 Jul 1995 00:00:00 GMT
Message-ID: <sci.med.diseases.lyme-CFV2@uunet.uu.net>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7107 news.groups:158576 sci.med:135050 sci.med.immunology:1963 alt.med.fibromyalgia:27089 alt.support.arthritis:5000 misc.health.arthritis:2126 bionet.microbiology:2694 sci.bio.microbiology:1216

                          LAST CALL FOR VOTES (of 2)
                   unmoderated group sci.med.diseases.lyme

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

Votes must be received by 23:59:59 UTC, 12 July 1995.

This vote is being conducted by a neutral third party.  For voting
questions only contact Warren Lavallee <warren@Syra.NET>.  For
questions about the proposed group contact Linda Palund
<monkeypa@dircon.co.uk>.

DISTRIBUTION
This CFV has been cross posted to:

  sci.med, sci.med.immunology, alt.med.fibromyalgia,
  alt.support.arthritis, misc.health.arthritis, bionet.microbiology,
  sci.bio.microbiology

And EMailed to:
	LymeNet <lymenet-l@lehigh.edu>

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

RATIONALE

        There is currently no discussion group for the many persons
suffering from or involved with Lyme Disease. The symptoms of Lyme
Disease are as varied as the terrain in which the disease carrying tick
thrives, and patients are often left isolated by their debilitating
symptoms in quite rural locations. Although there are Lyme Disease
support groups in various geographic locations, the severe limitations
of the symptoms experienced by patients make it often impossible for
them to physically attend these groups. This proposed newsgroup would
give housebound patients a much needed forum to discuss the disease,
as well as giving them the support they need. It will also enable
researchers and doctors from all over the medical and scientific
community who are studying this disease, to communicate via the Lyme
Disease newsgroup and could be invaluable help in the dissemination of
useful information to all persons concerned with Lyme
Disease.


HOW TO VOTE

Send MAIL to:   voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.

Your mail message should contain *one* and only one of the following
statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.
      I vote YES on sci.med.diseases.lyme
      I vote NO on sci.med.diseases.lyme
      I vote ABSTAIN on sci.med.diseases.lyme
      I CANCEL my vote on sci.med.diseases.lyme

Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)

Anything else may be rejected by the automatic vote counting program.  The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.

If you later change your mind you may vote again; only your last valid
vote will count.

Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)

In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.

If you give anyone a copy of the CFV, it must be whole and unmodified.

When in doubt, ask the votetaker.

Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.

The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.

There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.

From warren@syra.net Fri Jul 14 11:19:58 1995
Status: RO
Path: uunet!in1.uu.net!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology
Subject: RESULT: sci.med.diseases.lyme passes 131:13
Followup-To: news.groups
Date: 13 Jul 1995 20:26:03 -0400
Organization: Usenet Volunteer Votetakers
Lines: 237
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <sci.med.diseases.lyme-RESULT@uunet.uu.net>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7155 news.groups:159392 sci.med:135523 sci.med.immunology:1977 alt.med.fibromyalgia:27383 alt.support.arthritis:5058 misc.health.arthritis:2150 bionet.microbiology:2724 sci.bio.microbiology:1242

                                RESULT
            unmoderated group sci.med.diseases.lyme passes 131:13

There were 131 YES votes and 13 NO votes, for a total of 144 valid votes.
There were 4 abstains and 8 invalid ballots.

For group passage, YES votes must be at least 2/3 of all valid (YES and NO)
votes.   There also must be at least 100 more YES votes than NO votes.

There is a five day discussion period after these results are posted.  If no
serious allegations of voting irregularities are raised, the moderator of
news.announce.newgroups will create the group shortly thereafter.

  sci.med.diseases.lyme passed on Tue Jul 4 15:29:53 1995

Newsgroups line:
sci.med.diseases.lyme	Lyme Disease: patient support, research & information.

This vote was being conducted by a neutral third party. For voting
questions only contact Warren Lavallee <warren@Syra.NET>. For questions
about the proposed group contact Linda Palund <monkeypa@dircon.co.uk>.

CHARTER

        The proposed newsgroup, sci.med.diseases.lyme, is intended
for discussion about the many different aspects of Lyme Disease as
experienced by patients, their caregivers, friends and family members,
doctors and other medical professionals, or anyone affected by or
involved with Lyme Disease, as well as those who wish to learn about its
symptoms, latest treatment options and its prevention.

        Anyone with an interest in Lyme Disease is free to post,
including the medical and scientific community, as this newsgroup
is interested both in fostering communication between Lyme Disease
sufferers from all parts of the globe, as well as providing an open
forum for the exchange of medical and scientific information which
can be useful to all participants. Above all, we wish to encourage a
supportive and open atmosphere for the free exchange of opinions and
information.

The following are examples of possible posting topics:

- questions regarding any aspect of Lyme Disease
- symptoms and problems arising from the onset of new symptoms
- treatments and therapies, both conventional and alternative
- emotions, including fears and anxieties caused by this illness
- social issues regarding this illness
- problems in the medical community in regard to Lyme Disease
- new information and resources available about the disease
- related practical problems or solutions
- Lyme Disease research findings

Commercial advertisements may NOT be posted to this proposed group.

LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme

[This collection of addresses is (C)1995 by Consultix Computer Services.
Permission is strictly NOT given to use this list or any part thereof to
make a mailing list, or for mass-mailings.  Any other use is fine.]
sci.med.diseases.lyme Final Vote Ack

Voted Yes
------------------------------------------------------------------------------
adair@scr.siemens.com                                           Jonathan Adair
ahall@cs.uml.edu                                                   Andrew Hall
aimee@gov.nt.ca                                                 Aimee Phillpot
al715@yfn.ysu.edu                                                 Tina M. Wood
andrea.holtz@gmd.de
armhold@tenebris.rutgers.edu                                    George Armhold
AVIRAMA@UNIVSCVM.CSD.SCAROLINA.EDU                           Amittai F. Aviram
bailey@hagar.ph.utexas.edu                                           Ed Bailey
BK4Leg@aol.com
bkaim@unm.edu                                                   beth kaimowitz
bn293@cleveland.Freenet.Edu                                 Douglas P. Shannon
botteron@gnu.ai.mit.edu                                      Carol J. Botteron
BOWLESMK@SNYDELAB.DELHI.EDU
bparker@interaccess.com                                             Ben Parker
brian@geog.ubc.ca                                            Brian Klinkenberg
c96@vm.urz.uni-heidelberg.de
cdcge@sunset.backbone.olemiss.edu                    Christine Gilmore Eubanks
chicago@ix.netcom.com                                                  Chicago
clstampe@mailbox.syr.edu                                         Chris Stamper
cmn@icbdfcs3.fc.hp.com                                        Catherine Nelson
cnewport@netix.demon.co.uk                                       Chris Newport
colman@terraport.net                                           Colman M. Jones
croft@EMBL-Heidelberg.DE                                           David Croft
csinger@uxh.cso.uiuc.edu
darek@mulberry.com                                               Darek Iwanski
Darren_Abbanat_at_USPRMG41@internetmail.pr.cyanamid.com
DCSKYDIVE@aol.com
djenkins@midland.co.nz                                            Dean Jenkins
dmanley@eideti.com                                                 Dick Manley
dmurphy@olac.Berkeley.EDU                                          Doug Murphy
dporter@solar.sky.net                                            Donna Herrell
draziw@netcom.com                                                         Ryan
effie@gti.net                                                            effie
eugene@pioneer.arc.nasa.gov                                     Eugene N. Miya
giese@dev.cdx.mot.com                                              Bruce Giese
gomes@ICSI.Berkeley.EDU                                      Benedict A. Gomes
gonza006@maroon.tc.umn.edu                                        Pat Gonzales
grabowz@eng2.uconn.edu                                                     ZmG
grady@world.std.com                                                 Dick Grady
groo@netcom.com                                                    Kiran Wagle
gwb@Glue.umd.edu                                               George W. Baltz
hampson@csuvax1.murdoch.edu.au                                   David Hampson
hblatman@iac.net                                                   Hal Blatman
hermit@cats.ucsc.edu
HIRSCHBERG#m#_MARVIN@lims-a1.lerc.nasa.gov     Marvin Hirschberg (216)433-3206
HW1.JWONG2@HW1.CAHWNET.GOV                                           Jane Wong
igold@pasteur.fr                                                Dr Iain G. Old
IMMNTLRU@aol.com
janetk@no2sun.cray.com                                        Janet Kowalewski
jbyers@primenet.com                                             James M. Byers
jimst@ibeam.jf.intel.com
jknauerh@magnus.acs.ohio-state.edu                          Joyce A Knauerhase
JLEONG@OPAL.TUFTS.EDU
jmcgarry@uoguelph.ca
JMH1968@aol.com
jmlake@cogsci.uiuc.edu                                               Mike Lake
jod@equator.com                                           John Setel O'Donnell
joelh@rdz.stjohns.edu                                           Joel Hornstein
jolsen@mod.com                                                       Jim Olsen
jonboy@io.org                                                           Jonboy
joseph@cis.ohio-state.edu                                        Sudish Joseph
joy@nr-atp.cit.cornell.edu                                       Joy Veronneau
jperrin@umich.edu
jrsherlo@prairienet.org                                       John R. Sherlock
jwlester@ucdavis.edu                                               John Lester
Karl-Heinz.Kuhn@biologie.uni-regensburg.de               Karl-Heinz Kuhn t2150
kathy@aztec.asu.edu                                          KATHY L. BIRDWELL
ken@thor.ST.3Com.COM                                            Ken Descoteaux
kimketo@utu.fi                               Kimmo Ketolainen +358 40 500 2957
knauer@ibeam.jf.intel.com                                       Rob Knauerhase
kundry@crl.com                                                 Trisha Benedict
lapoint@ARL.MIL                                        Claude Lapointe (ACISD)
list-votes@dream.hb.north.de                                  Martin Schr"oder
lthomas@SIRIUS.COM                                                  Les Thomas
M.Davidson@isode.com                                        Madelaine Davidson
mac7@po.CWRU.Edu                                              Michael A. Chary
marc@world.std.com                                              Marc Dashevsky
mbrosseau@mhv.net
mkc@graphics.cornell.edu                                    Mitch Collinsworth
monkeypa@dircon.co.uk                                             Linda Palund
moore@easi.com                                                 Robert K. Moore
morse@dorsai.dorsai.org                                          Michael Ricci
msnirhod@olive.mscc.huji.ac.il                                     Omer Nirhod
mstern@lindsay.Princeton.EDU                                  Marlene J. Stern
ndallen@io.org                                                     Nigel Allen
nelial@netcom.com                                                   Nelia Lyda
nhaven1@minerva.cis.yale.edu                           North Haven High School
nick@inferno.fc.hp.com                                          Nick Ingegneri
norman.birkett@gs.com                                           Norman Birkett
paula@VFL.Paramax.COM
pdecker@lds.loral.com                                            Philip Decker
Peter.Rohleder@gmd.de                                           Peter Rohleder
pimentel@roots.ultranet.com                                      John Pimentel
pp002773@interramp.com                                            Jim DePietro
PTYZEN@Gems.VCU.EDU
radman@teleport.com
radrayer@panix.com                                              Rebecca Drayer
randolph.little@att.com                                             R.S.LITTLE
rconnell@sadis05.kelly.af.mil                         RALPH W. CONNELL - LGSPI
rebotis@crocker.com                                               Rebecca Otis
redfox@VNET.IBM.COM
RenieTlr@aol.com
RGINZBERG@EAGLE.WESLEYAN.EDU                                     Ruth Ginzberg
rgyure@aol.com                                                          RGyure
rick@bcm.tmc.edu                                             Richard H. Miller
rlevy@lonestar.jpl.utsa.edu                                  Robert M. Levy
rmpol@netcom.com
roger@marshall.manawatu.planet.co.nz                            Roger Marshall
rsc@advanced.org                                                    R. S. Camm
rsmits@ham.island.net                                             Robert Smits
rufinus@mbe.ece.wisc.edu                                       Jeffrey Rufinus
sctdr@cr41.staffs.ac.uk                                           David Revitt
shelley@netcom.com                                                      shells
shimeall@cs.nps.navy.mil                                      timothy shimeall
shorton@ic.sunysb.edu                                        Schuyler W Horton
singer@ortel.org                                                    Gil Singer
snowhite@aa.net                                                 Linda W. White
sonata@eskimo.com                                                     Boudicca
stonesifer#m#_phyllis@msgw.vf.mmc.com                      Stonesifer, Phyllis
str@crl.com                                                      Steve Roberts
s_rich@nocmsmgw.harvard.edu                                             s rich
tanks@banks.iii.net                                             Barnet Sherman
tccn@tccn.com                                                 Coralie J. Allen
teleganp@derm.med.upenn.edu                                      Patti Telegan
tgm@netcom.com                                            Thomas G. McWilliams
Ticktalk2@aol.com
tsinger@u.washington.edu                                             T. Singer
twpierce@midway.uchicago.edu                                        Tim Pierce
UGM3AA@SOUTH-01.NOVELL.LEEDS.AC.UK                               Abdul W Abdul
ulf.garpmo@ng.hik.se                                                Ulf Garpmo
wanagin@kingkong.escape.de                                      Ulf Bahrenfuss

Voted No
------------------------------------------------------------------------------
ahm@sashimi.wwa.com                                        Andrew H. Marrinson
akilgour@thinkage.on.ca                                          Anita Kilgour
balaji@nexus.yorku.ca                                                   Balaji
csaamw@urc.tue.nl                                               Michiel Wijers
ed@crl.com                                                         Ed Anderson
ed@titipu.resun.com                                                Edward Reid
ewl@panix.com                                                   Emery Lapinski
hitech@primenet.com                                                     HiTech
jbl@levin.MV.COM                                                  Joel B Levin
kshojani@wimsey.com                                           Kam Shojania, MD
smarry@turing.toronto.edu                                         Smarasderagd
stainles@bga.com                                                  Dwight Brown
widenius@cc.helsinki.fi                                         Risto Widenius

Abstained
------------------------------------------------------------------------------
crouchkp@flidh101.delcoelect.com                              Kenneth P Crouch
Edward_McSweegan@exec.niaid.pc.niaid.nih.gov                  Edward McSweegan
huuskone@cc.helsinki.fi                                       Taneli Huuskonen
mmt@RedBrick.COM                                          M Mike Taksar KC6ZPS


Votes in error
------------------------------------------------------------------------------
camilla@primenet.com                                        Camilla Cracchiolo
   ! No vote statement in message
ewinner@ix.netcom.com                                                  ewinner
   ! No vote statement in message
ivheij@IAEhv.nl                                            Ivar van Heijningen
   ! No vote statement in message
jolynch@access.digex.net                                         Johanna Lynch
   ! No vote statement in message
mreeves@ns.net                                               Michael J. Reeves
   ! No vote statement in message
news@news.doas.state.ga.us                                    NEWS News Admin.
   ! Invalid address
revans@dsm1.dsmnet.com                                         Robert M. Evans
   ! No vote statement in message
root@hosp5.phklug.mednet.com                               Vladimir A. Bolibok
   ! Invalid address

 
USENET FACT: Flaming
Flaming is the hostile interaction between multiple Usenet users.